Heidi Health vs Revvity
Side-by-side comparison of AI visibility scores, market position, and capabilities
Australian AI clinical documentation platform. Used by Monash Health (1.6M patients). $96.6M raised ($65M Series B at $465M valuation). Founded 2019, Melbourne.
About
Heidi Health was founded in 2019 in Melbourne, Australia by Dr. Thomas Kelly and Ryan Wright to eliminate the administrative burden of clinical documentation for healthcare providers. Clinicians spend 30–50% of working hours on documentation — typing notes, generating referral letters, completing forms — time that could otherwise go to patient care. Heidi built an ambient AI documentation platform that listens to patient consultations, transcribes in real time, and automatically generates structured clinical notes and referral letters tailored to each clinician's specialty.\n\nThe platform integrates with major EHR systems to push completed notes directly into patient charts, eliminating copy-paste friction. The AI engine supports general practice, specialist medicine, allied health, and nursing, and learns each clinician's personal documentation style over time to reduce editing effort. Heidi is deployed at Monash Health in Victoria, one of Australia's largest public health networks serving 1.6 million patients, as a flagship enterprise reference deployment.\n\nHeidi Health has raised $96.6 million in total funding, including a $65 million Series B at a $465 million valuation. The company is one of the fastest-growing clinical documentation AI platforms in Australia and is expanding internationally. As health systems globally address clinician burnout driven by documentation load, ambient AI documentation is emerging as a high-ROI technology investment, positioning Heidi Health alongside US-based competitors including Nuance DAX and Suki.
Revvity (RVTY) reported ~$2.9B revenue in FY2024. Life science tools and diagnostics company providing instruments, reagents, and software for genomics, newborn screening, and drug discovery. HQ: Waltham, MA.
About
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provider of solutions for reproductive health, genomics, and applied markets. The company operates in two segments: Life Sciences (analytical instruments, reagents, software for pharmaceutical and academic research) and Diagnostics (immunoassay and molecular diagnostic systems for clinical and screening applications). Revvity is the global leader in newborn screening, processing the tests that check newborns for metabolic and genetic disorders shortly after birth.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.